A detailed history of Brown Financial Advisors transactions in Pfizer Inc stock. As of the latest transaction made, Brown Financial Advisors holds 46,542 shares of PFE stock, worth $1.2 Million. This represents 0.44% of its overall portfolio holdings.

Number of Shares
46,542
Previous 55,047 15.45%
Holding current value
$1.2 Million
Previous $1.39 Billion 19.12%
% of portfolio
0.44%
Previous 0.58%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 15, 2025

SELL
$21.59 - $24.84 $183,622 - $211,264
-8,505 Reduced 15.45%
46,542 $1.13 Billion
Q1 2025

May 12, 2025

BUY
$25.01 - $27.13 $75,155 - $81,525
3,005 Added 5.77%
55,047 $1.39 Billion
Q4 2024

Feb 04, 2025

BUY
$24.8 - $30.19 $202,219 - $246,169
8,154 Added 18.58%
52,042 $1.38 Billion
Q3 2024

Nov 15, 2024

BUY
$27.7 - $31.39 $517,546 - $586,490
18,684 Added 74.13%
43,888 $1.27 Billion
Q2 2024

Aug 30, 2024

BUY
$25.26 - $29.6 $636,653 - $746,038
25,204 New
25,204 $705 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $144B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Brown Financial Advisors Portfolio

Follow Brown Financial Advisors and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Brown Financial Advisors, based on Form 13F filings with the SEC.

News

Stay updated on Brown Financial Advisors with notifications on news.